Cryptococcosis mimicking cutaneous cellulitis in a patient suffering from rheumatoid arthritis: A case report

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Probst, Corina ^a   Pongratz, Georg ^a   Capellino, Silvia ^a   Szeimies, Rolf M ^b   Schölmerich, Jürgen ^a   Fleck, Martin ^a   Salzberger, Bernd ^a   Ehrenstein, Boris ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Klinikum Vest   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; FLUCONAZOLE; PIPERACILLIN; PREDNISOLONE; SULBACTAM; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; STEROID;

AGED; ARM DISEASE; ARTICLE; BACTERIAL CELLULITIS; CASE REPORT; CELLULITIS; CRYPTOCOCCUS NEOFORMANS; CUTANEOUS CRYPTOCOCCOSIS; DEBRIDEMENT; DIAGNOSTIC ERROR; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; NECROTIZING CELLULITIS; PERIODIC ACID SCHIFF STAIN; PYODERMA; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN TRANSPLANTATION; SKIN ULCER; SOFT TISSUE DISEASE; TREATMENT DURATION; WOUND; CRYPTOCOCCOSIS; CYTOCHEMISTRY; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROSCOPY; PATHOLOGY; SKIN; TREATMENT OUTCOME;

AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; ARTHRITIS, RHEUMATOID; CELLULITIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DEBRIDEMENT; FEMALE; FLUCONAZOLE; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOCOMPROMISED HOST; MICROSCOPY; SKIN; STEROIDS; TREATMENT OUTCOME;

EID: 77955369722     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-239     Document Type: Article

References (26)

1. Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR, Diezmann S, et al. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 2005, 437(7063):1360-4. 10.1038/nature04220, 16222245.
2. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004, 101(49):17258-63. 10.1073/pnas.0402981101, 535360, 15572442.
3. Faganello J, Dutra V, Schrank A, Meyer W, Schrank IS, Vainstein MH. Identification of genomic differences between Cryptococcus neoformans and Cryptococcus gattii by Representational Difference Analysis (RDA). Med Mycol 2009, 47(6):584-91. 10.1080/13693780802272148, 18668420.
4. Bovers M, Hagen F, Kuramae EE, Diaz MR, Spanjaard L, Dromer F, et al. Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii. FEMS Yeast Res 2006, 6(4):599-607. 10.1111/j.1567-1364.2006.00082.x, 16696655.
5. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 2000, 31(2):499-508. 10.1086/313992, 10987712.
6. Lazera MS, Cavalcanti MA, Trilles L, Nishikawa MM, Wanke B. Cryptococcus neoformans var. gattii--evidence for a natural habitat related to decaying wood in a pottery tree hollow. Med Mycol 1998, 36(2):119-22.
7. Haag-Wackernagel D, Moch H. Health hazards posed by feral pigeons. J Infect 2004, 48(4):307-13. 10.1016/j.jinf.2003.11.001, 15066331.
8. Christianson JC, Engber W, Andes D. Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts. Med Mycol 2003, 41(3):177-88. 10.1080/1369378031000137224, 12964709.
9. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23(4):525-30. 10.1097/QAD.0b013e328322ffac, 19182676.
10. Jasch KC, Hermes B, Scheller U, Harth W. Pyoderma gangrenosum-like primary cutaneous cryptococcosis. Acta Derm Venereol 2008, 88(1):76-7. 10.2340/00015555-0328, 18176763.
11. Lu HC, Yang YY, Huang YL, Chen TL, Chuang CL, Lee FY, et al. Disseminated cryptococcosis initially presenting as cellulitis in a rheumatoid arthritis patient. J Chin Med Assoc 2007, 70(6):249-52. 10.1016/S1726-4901(09)70368-5, 17591585.
12. Singh N, Dromer F, Perfect JR, Lortholary O. Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis 2008, 47(10):1321-7. 10.1086/592690, 2696098, 18840080.
13. Vilchez RA, Fung J, Kusne S. Cryptococcosis in organ transplant recipients: an overview. Am J Transplant 2002, 2(7):575-80. 10.1034/j.1600-6143.2002.20701.x, 12201357.
14. Reisfeld-Zadok S, Elis A, Szyper-Kravitz M, Chowers M, Lishner M. Cryptococcal meningitis in chronic lymphocytic leukemia patients. Isr Med Assoc J 2009, 11(7):437-9.
15. Revenga F, Paricio JF, Merino FJ, Nebreda T, Ramirez T, Martinez AM. Primary cutaneous cryptococcosis in an immunocompetent host: case report and review of the literature. Dermatology 2002, 204(2):145-9. 10.1159/000051835, 11937743.
16. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003, 36(6):789-94. 10.1086/368091, 12627365.
17. Dromer F. Cryptococcosis. Rev Prat 2001, 51(7):738-41.
18. Neuville S, Dromer F, Morin O, Dupont B, Ronin O, Lortholary O. Primary cutaneous cryptococcosis: a distinct clinical entity. Clin Infect Dis 2003, 36(3):337-47. 10.1086/345956, 12539076.
19. Kwon-Chung KJ, Sorrell TC, Dromer F, Fung E, Levitz SM. Cryptococcosis: clinical and biological aspects. Med Mycol 2000, 38(Suppl 1):205-13.
20. Naka W, Masuda M, Konohana A, Shinoda T, Nishikawa T. Primary cutaneous cryptococcosis and Cryptococcus neoformans serotype D. Clin Exp Dermatol 1995, 20(3):221-5. 10.1111/j.1365-2230.1995.tb01306.x, 7671417.
21. Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981, 60(4):288-97.
22. Scott DG, Bacon PA, Allen C, Elson CJ, Wallington T. IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol 1981, 43(1):54-63. 1537119, 7249394.
23. Voskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JM. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis 1996, 55(3):190-2. 10.1136/ard.55.3.190, 1010127, 8712883.
24. Geirsson AJ, Sturfelt G, Truedsson L. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis 1987, 46(10):727-33. 10.1136/ard.46.10.727, 1003378, 3689000.
25. Mongan ES, Cass RM, Jacox RF, Vaughen JH. A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis. Am J Med 1969, 47(1):23-35. 10.1016/0002-9343(69)90238-1, 4183354.
26. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 2010, 50(3):291-322. 10.1086/649858, 20047480.